Zilico's cervical cancer diagnostic device lands CE Mark

Zilico Ltd has received EC certification from its Notified Body for its cervical cancer diagnostics device, ZedScan I. The UK company's ground-breaking system offers quicker and more accurate detection of cervical neoplasia in real-time, enabling clinicians to improve patient management. The ZedScan I system is used alongside colposcopy on women identified with an abnormal smear result. ZedScan offers clinical benefits by identifying the optimum biopsy site and so reducing the number of cervical biopsies required whilst also facilitating a wider use of 'select & treat'...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news